Analystreport

CTI BioPharma (NASDAQ: CTIC) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating.

CTI BioPharma Corp.  (CTIC) 
Last cti biopharma corp. earnings: 11/1 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ctibiopharma.com